tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
VTGN
VistaGen Therapeutics
RESEARCH TOOLSreports
Want to see VTGN full AI Analyst Report?

VistaGen Therapeutics (VTGN) Ratios

1,149 Followers

VistaGen Therapeutics Ratios

VTGN's free cash flow for Q1 2027 was $0.87. For the 2027 fiscal year, VTGN's free cash flow was decreased by $ and operating cash flow was $-8.83. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.07 3.67 6.51 23.55 3.83
Quick Ratio
 3.07 3.67 6.51 23.55 3.83
Cash Ratio
 1.52 2.41 5.32 23.26 3.64
Solvency Ratio
 -5.94 -5.29 -3.64 -3.07 -6.52
Operating Cash Flow Ratio
 -5.57 -5.19 -3.34 -5.04 -10.87
Short-Term Operating Cash Flow Coverage
 -86.52 -692.04 0.00 0.00 -473.49
Net Current Asset Value
$ 23.05M$ 33.90M$ 68.13M$ 111.31M$ 8.50M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.02 0.02 0.13
Debt-to-Equity Ratio
 0.03 0.03 0.02 0.02 0.22
Debt-to-Capital Ratio
 0.03 0.03 0.02 0.02 0.18
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.46 1.37 1.20 1.08 1.75
Debt Service Coverage Ratio
 -93.48 -743.75 0.00 0.00 -458.92
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -2.58K
Debt to Market Cap
 0.07 <0.01 0.00 0.00 <0.01
Interest Debt Per Share
 0.02 0.03 0.05 0.11 0.39
Net Debt to EBITDA
 0.24 0.42 1.29 3.61 0.24
Profitability Margins
Gross Profit Margin
84.57%100.00%100.00%100.00%100.00%
EBIT Margin
-2720.34%-5683.69%-10578.40%-3103.48%26109.25%
EBITDA Margin
-2689.93%-5625.93%-10447.74%-3050.09%25874.89%
Operating Profit Margin
-2784.33%-5683.69%-11517.08%-3103.48%26109.25%
Pretax Profit Margin
-2702.36%-5490.78%-10578.40%-2759.21%26097.80%
Net Profit Margin
-2702.64%-5491.33%-10579.84%-2759.59%26100.44%
Continuous Operations Profit Margin
-2702.64%-5491.33%-10579.84%-2759.59%26100.44%
Net Income Per EBT
100.01%100.01%100.01%100.01%100.01%
EBT Per EBIT
97.06%96.61%91.85%88.91%99.96%
Return on Assets (ROA)
-189.22%-143.49%-60.96%-23.75%-280.94%
Return on Equity (ROE)
-152.59%-196.19%-73.05%-25.69%-490.46%
Return on Capital Employed (ROCE)
-283.83%-201.64%-78.03%-27.86%-358.87%
Return on Invested Capital (ROIC)
-275.74%-197.26%-77.43%-27.73%-346.47%
Return on Tangible Assets
-189.22%-143.49%-60.96%-23.75%-280.94%
Earnings Yield
-646.91%-320.25%-66.61%-28.09%-236.50%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 -0.28
Payables Turnover
 0.39 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 2.42 1.03 0.27 0.47 -0.08
Asset Turnover
 0.07 0.03 <0.01 <0.01 -0.01
Working Capital Turnover Ratio
 0.09 0.02 <0.01 0.02 >-0.01
Cash Conversion Cycle
 -945.60 0.00 0.00 0.00 -1.29K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 -1.29K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 945.60 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 -1.29K
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.45 -1.74 -1.36 -1.33 -7.14
Free Cash Flow Per Share
 -1.45 -1.74 -1.37 -1.34 -7.17
CapEx Per Share
 0.00 <0.01 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -439.97 -220.40 -423.16 -234.51
Capital Expenditure Coverage Ratio
 0.00 -439.97 -220.40 -423.16 -234.51
Operating Cash Flow Coverage Ratio
 -79.56 -63.64 -27.90 -12.18 -18.34
Operating Cash Flow to Sales Ratio
 -24.90 -52.35 -86.62 -24.26 219.01
Free Cash Flow Yield
-577.23%-305.32%-54.78%-24.76%-199.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.14 -0.31 -1.50 -3.56 -0.42
Price-to-Sales (P/S) Ratio
 4.31 17.15 158.83 98.23 -110.36
Price-to-Book (P/B) Ratio
 0.43 0.61 1.10 0.91 2.07
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.17 -0.33 -1.83 -4.04 -0.50
Price-to-Operating Cash Flow Ratio
 -0.17 -0.33 -1.83 -4.05 -0.50
Price-to-Earnings Growth (PEG) Ratio
 -0.04 -0.03 -0.15 0.04 -0.03
Price-to-Fair Value
 0.43 0.61 1.10 0.91 2.07
Enterprise Value Multiple
 0.08 0.11 -0.23 0.39 -0.19
Enterprise Value
 -5.42M -7.99M 11.57M -12.53M 11.12M
EV to EBITDA
 0.08 0.11 -0.23 0.39 -0.19
EV to Sales
 -2.16 -6.29 23.81 -11.78 -49.01
EV to Free Cash Flow
 0.09 0.12 -0.27 0.48 -0.22
EV to Operating Cash Flow
 0.09 0.12 -0.27 0.49 -0.22
Tangible Book Value Per Share
 0.57 0.93 2.28 5.90 1.74
Shareholders’ Equity Per Share
 0.57 0.93 2.28 5.90 1.74
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.06 0.03 0.02 0.05 -0.03
Net Income Per Share
 -1.57 -1.83 -1.67 -1.52 -8.51
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.99 0.97 1.00 0.89 1.00
Research & Development to Revenue
 21.60 43.32 81.02 18.82 -195.49
SG&A to Revenue
 7.17 14.52 35.15 13.22 -64.60
Stock-Based Compensation to Revenue
 1.63 3.15 8.88 2.05 -14.70
Income Quality
 0.92 0.95 0.82 0.88 0.84
Currency in USD